ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation
Journal of Clinical Investigation · 17.03.2025 · 135 (6)
DOI: 10.1172/jci180242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 04.02.2025. Verfasst von Di Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Lipoylation, Proto-Oncogene Proteins p21(ras), Acyltransferases, Kidney. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Initiation Fund of Qingyuan People’s Hospital, Xinjiang Uygur Autonomous Region Human Resources and Social Security Department.
Abstract (Originalsprache)
Fibrosis is the final common pathway leading to end-stage chronic kidney disease (CKD). However, the function of protein palmitoylation in renal fibrosis and the underlying mechanisms remain unclear. In this study, we observed that expression of the palmitoyltransferase ZDHHC18 was significantly elevated in unilateral ureteral obstruction (UUO) and folic acid–induced (FA-induced) renal fibrosis mouse models and was significantly upregulated in fibrotic kidneys of patients with CKD. Functionally, tubule-specific deletion of ZDHHC18 attenuated tubular epithelial cells’ partial epithelial-mesenchymal transition (EMT) and then reduced the production of profibrotic cytokines and alleviated tubulointerstitial fibrosis. In contrast, ZDHHC18 overexpression exacerbated progressive renal fibrosis. Mechanistically, ZDHHC18 catalyzed the palmitoylation of HRAS, which was pivotal for its translocation to the plasma membrane and subsequent activation. HRAS palmitoylation promoted downstream phosphorylation of MEK/ERK and further activated Ras-responsive element–binding protein 1 (RREB1), enhancing SMAD binding to the Snai1 cis -regulatory regions. Taken together, our findings suggest that ZDHHC18 plays a crucial role in renal fibrogenesis and represents a potential therapeutic target for combating kidney fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
- Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.
- Department of Pediatrics, Jiangxi Children's Medical Center, Nanchang, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences and Zhongshan Hospital, Fudan University, Shanghai, China.
- The Key Laboratory of Experimental Teratology of the Ministry of Education and Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Förderung
- Postdoctoral Initiation Fund of Qingyuan People’s Hospital
- Xinjiang Uygur Autonomous Region Human Resources and Social Security Department
Zitieren
APA
Lu, D., Aji, G., Li, G., Li, Y., Fang, W., Zhang, S., Yu, R., Jiang, S., Gao, X., Jiang, Y., & Wang, Q. (2025). ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci180242
Vancouver
Lu D, Aji G, Li G, Li Y, Fang W, Zhang S, et al. ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation. Journal of Clinical Investigation. 2025;135(6). doi:10.1172/jci180242
BibTeX
@article{Lu2025,
author = {Lu, Di and Aji, Gulibositan and Li, Guanyu and Li, Yue and Fang, Wenlin and Zhang, Shuai and Yu, Ruiqi and Jiang, Sheng and Gao, Xia and Jiang, Yuhang and Wang, Qi},
title = {ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {6},
doi = {10.1172/jci180242}
}
EUVIMED